A systematic review by Isobel Blanksby and Holly Carding found that menopausal symptoms had a significant impact on the well-being and productivity of NHS staff. Given that women… read more.
Scientists have uncovered how lymphatic vessels – the kidney’s ‘plumbing system’ – undergo dramatic changes during chronic transplant rejection, becoming structurally disorganised and spreading to unusual parts of… read more.
Pharmacist-led menopause clinics in the NHS The provision of accessible and specialised menopause care within the National Health Service (NHS) has historically faced significant challenges, often leaving patients… read more.
Despite rising patient demand and commitments to strengthen primary care, one in three GPs with a licence to practise in England are not working in NHS general practice,… read more.
A network analysis of more than 26,000 dogs and their health conditions helps reveal which diseases tend to go together, providing data that veterinarians and researchers can use… read more.
The guideline was developed in line with internationally recognised standards, including the GRADE methodology and the RIGHT reporting statement, and reflects the EASD’s newly established Standard Operating Procedures… read more.
Research supported by the National Institutes of Health (NIH) shows that repeated head impacts from contact sports can cause early and lasting changes in the brains of young-… read more.
Merck KGaA, announced that the European Commission (EC) granted marketing authorization for Ogsiveo (nirogacestat), an oral gamma secretase inhibitor, as monotherapy for the treatment of adults with progressing… read more.
Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer’s disease. The diagnostic is intended for use in primary care. Using a tablet… read more.
Eisai Co., Ltd. announced that the in-house discovered and developed orexin receptor antagonist Dayvigo (brand name in China: “达卫可®“ generic name: lemborexant) has launched in China for the… read more.
The rise in gestational diabetes mellitus (GDM) could, in part, be caused by excess maternal folate levels, according to a new study. These high doses of folate are… read more.
KalVista Pharmaceuticals, Inc. announced the acceptance of six abstracts for ePoster presentation at the 20th German Allergy Congress taking place in Düsseldorf, Germany from October 2–4, 2025. Details… read more.
High glucose levels could serve as a biomarker indicating a worse outcome in patients who have experienced their first acute myocardial infarction, according to researchers in Brazil. The… read more.
Lund, Sweden, 26 September, 2025. Hansa Biopharma AB, “announced that Genethon will present preliminary efficacy and safety data from the first patient treated in the GNT-018-IDES Phase II… read more.
More than half of all adults without diabetes who began taking semaglutide discontinued treatment within a year, according to new research on Danish patients. The population-wide study was… read more.
Novartis will present new data from 34 abstracts across its oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin (October 17-21, 2025). “We… read more.
Women who selectively purchase personal care products based on their ingredients were successfully able to lower their exposures to several chemicals associated with health risks. The peer-reviewed findings… read more.
In an analysis by race, sex, age, and geography, alcohol-induced death rates in 2024 are nearly double those in 1999, with a sharp increase at the onset of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
